Cite
MLA Citation
D.F. McDermott et al.. “2622 A Phase I/II study to assess the safety and efficacy of pazopanib (paz) and pembrolizumab (pembro) in patients (pts) with advanced renal cell carcinoma (aRCC).” European journal of cancer, vol. 51, n.d., pp. S519–S520. http://access.bl.uk/ark:/81055/vdc_100030628262.0x000003